104
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Risk Factors for COVID-19 Infection in Adult Patients: A Retrospective Observational Study in Japan

, , & ORCID Icon
Pages 441-448 | Received 12 Oct 2023, Accepted 15 Jan 2024, Published online: 02 Feb 2024

References

  • Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.105924
  • Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
  • Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46(13):2235–2240. doi:10.1038/s41386-021-00978-8
  • Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi:10.1016/S0140-6736(20)32656-8
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
  • Ambrosino I, Barbagelata E, Ortona E, et al. Gender differences in patients with COVID-19: a narrative review. Monaldi Arch Chest Dis. 2020;90:2. doi:10.4081/monaldi.2020.1389
  • Nasirpour N, Esmailzadehha N, Hajebi A, Savari E, Ghanbari B, Motevalian A. Preexisting depression and COVID-19: a cohort study on the risk of susceptibility and hospitalization. BMC Psychiatry. 2023;23(1):942. doi:10.1186/s12888-023-05438-9
  • Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of covid-19? BMJ. 2020;369:m1548. doi:10.1136/bmj.m1548
  • Luoyi H, Yan P, Qihong F, Anand V. Relationship between angiotensin-converting enzyme insertion/deletion polymorphism and the risk of COVID-19: a meta-analysis. J Renin Angiot Aldost Syst. 2023;2023:3431612. doi:10.1155/2023/3431612
  • Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992. doi:10.1053/j.ajkd.2008.12.034
  • Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging. 2020;12(13):12493–12503. doi:10.18632/aging.103579
  • Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi:10.1016/j.jinf.2020.04.021
  • Ayoub HH, Chemaitelly H, Mumtaz GR, et al. Characterizing key attributes of COVID-19 transmission dynamics in China’s original outbreak: model-based estimations. Global Epidemiol. 2020;2:100042. doi:10.1016/j.gloepi.2020.100042
  • Pijls BG, Jolani S, Atherley A, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ open. 2021;11(1):e044640. doi:10.1136/bmjopen-2020-044640
  • Huck DM, Buckley LF, Chandraker A, Blankstein R, Weber B. Targeting pharmacotherapies for inflammatory and cardiorenal endpoints in kidney disease. J Cardiovasc Pharmacol. In press 2024. doi:10.1097/FJC.0000000000001482
  • Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The Role of Inflammation in CKD. Cells. 2023;12(12):1581. doi:10.3390/cells12121581.
  • Lewington S, Whitlock G; Prospective Studies C. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829–1839. doi:10.1016/S0140-6736(07)61778-4
  • van der Steeg WA, Holme I, Boekholdt SM, et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol. 2008;51(6):634–642. doi:10.1016/j.jacc.2007.09.060
  • Wang G, Zhang Q, Zhao X, et al. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis. 2020;19(1):204. doi:10.1186/s12944-020-01382-9
  • Feingold KR. The bidirectional link between HDL and COVID-19 infections. J Lipid Res. 2021;62:100067. doi:10.1016/j.jlr.2021.100067
  • Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in community-acquired pneumonia. Am j Nephrol. 2007;27(2):184–190. doi:10.1159/000100866
  • Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest. 2020;43(8):1137–1139. doi:10.1007/s40618-020-01301-w
  • Frontera JA, Valdes E, Huang J, et al. Prevalence and impact of hyponatremia in patients with coronavirus disease 2019 in New York City. Crit Care Med. 2020;48(12):e1211–e1217. doi:10.1097/CCM.0000000000004605
  • Hu W, Lv X, Li C, et al. Disorders of sodium balance and its clinical implications in COVID-19 patients: a multicenter retrospective study. Int Emerg Med. 2021;16(4):853–862. doi:10.1007/s11739-020-02515-9
  • Tezcan ME, Dogan Gokce G, Sen N, Zorlutuna Kaymak N, Ozer RS. Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized coronavirus disease 2019 patients. New Microb New Infect. 2020;37:100753. doi:10.1016/j.nmni.2020.100753
  • Bae M, Kim H. Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19. Molecules. 2020;25(22):5346. doi:10.3390/molecules25225346
  • Liu Y, Zhang H, Yuan G, et al. The impact of circadian rhythms on the immune response to influenza vaccination in middle-aged and older adults (IMPROVE): a randomised controlled trial. Immun Ageing. 2022;19(1):46. doi:10.1186/s12979-022-00304-w
  • Guidelines ZC-T. Available from: https://wwwcovid19treatmentguidelinesnihgov/therapies/supplements/zinc/. Accessed January 17, 2024.
  • Wolf J, Rink L. Handbook on the Toxicology of Metals. 5th ed. Elsevier; 2022:963–984.